SAN FRANCISCO (MedPage Today) -- Sequential targeted therapy for metastatic renal cell carcinoma led to similar survival, regardless of which agent was used first, according to the first randomized study of the issue. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment